Dr. Steven Finkelstein Named Chief Science Officer at 21st Century Oncology

SCOTTSDALE, Ariz. - Nov. 4, 2014 - PRLog -- 21^st Century Oncology, the nation’s leading provider of cancer care services, has recently appointed Scottsdale Board Certified Radiation Oncologist, Steven Finkelstein, M.D., as the company’s national Chief Science Officer. This role will allow Dr. Finkelstein to expand his commitment to cancer research and clinical trials in the Arizona community, as well as 21^st Century Oncology’s locations across the nation.

“Dr. Finkelstein has demonstrated a continuous commitment to provide cancer patients with access to novel therapies in the local communities he serves,” says Constantine Mantz, M.D., Chief Medical Officer of 21^st Century Oncology. “We are proud he accepted the offer to become the company’s Chief Science Officer to expand access to local clinical trials to cancer patients nationwide.”

Dr. Finkelstein is an expert in prostate cancer and sarcoma and has a special interest in patient care and research of a variety of cancers, using radiation-driven, personalized systemic therapy. Accordingly, he holds three international patents pending in cutting edge technologies. He has given national and international lectures, published numerous professional journal articles, and written book chapters, resulting in over 2,000 reference citations.

He has various leadership roles in the American Society of Clinical Oncology, the American Society for Therapeutic Radiology and Oncology, Radiological Society of North America, and the Radiation Therapy Oncology Group. Dr. Finkelstein also serves as the National Director of the Translational Research Consortium, the research arm of 21^st Century Oncology, Adjunct Associate Professor at the Translational Genomic Research Institute (TGen), Vice Chair of Translational Research for Southwest Oncology Group (SWOG) Radiation committee, and editor-in-chief of the Journal, Contemporary Radiation Oncology.

“With this new role, I look forward to advancing the company’s mission of increasing patient access to novel cancer care,” says Dr. Finkelstein. “I am proud to better serve cancer patients nationwide by providing access to clinical trials in local communities, close to patient’s homes.”

Dr. Finkelstein earned his medical degree from the University of Michigan Medical School. He was chief resident in Radiation Oncology at Moffitt Cancer Center in Tampa, Fla. He also completed fellowship training in surgical oncology, as well as clinical immunotherapy, with the National Cancer Institute, National Institutes of Health, in Bethesda, Md.

For more information about our services, visit http://www.21cOncologyArizona.com or call 480-945-6896.

About 21^st Century Oncology:

21^st Century Oncology is the largest global, physician led provider of Integrated Cancer Care services. The company offers a comprehensive range of cancer treatment services, focused on delivering academic quality, cost-effective patient care in personal and convenient settings. The company operates 175 treatment centers, including 140 centers located in 16 states. The company also operates 35 centers located in six countries in Latin America. The company holds market-leading positions in most of its domestic local markets and abroad.